Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06441253
Other study ID # MSRSW/Batch-Fall22/718
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 1, 2023
Est. completion date October 29, 2024

Study information

Verified date June 2024
Source Superior University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research aimed to contribute valuable insights into the potential benefits of incorporating the portable wedge device into preventive or therapeutic interventions for calf-related musculoskeletal issues.


Description:

By combining economical, ergonomic principles and user-friendly features, the proposed device offered individuals a convenient and efficient means to enhance their calf flexibility, ultimately mitigating strain and reducing spasms. Developing and successfully integrating a portable wedge device could mark a significant breakthrough in preventive and rehabilitative care for musculoskeletal problems associated with the calf region. This innovative device can enhance the overall well-being and musculoskeletal health of individuals suffering from such issues, providing a more effective and convenient treatment solution.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 26
Est. completion date October 29, 2024
Est. primary completion date May 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Male and female patients diagnosed with Calf Strain and Spasm - Age above 18 - Participants who are volunteer for the study - Patients who suffer from leg pain or functional disability Exclusion Criteria: - Unconscious patients - Patients with difficulty in seeing and hearing - Patients having a history of mental illnesses (Stroke, Multiple sclerosis, Parkinsonism, Alzheimer's Disease) - Patient history of severe mobility disorder - Systemic illness (Liver Failure, Active cancer, Cardiopulmonary distress) - Decline to participate in this study - Active fracture and dislocations - Arthritic disorders (such as osteoarthritis, Rheumatoid Arthritis, Psoriatic Arthritis, and Fibromyalgia)

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Deep Friction massage
The calf muscles received a firm, deep-circulation massage with fingertip pressure
Combination Product:
Therapeutic exercises
Four stretching exercises were performed for twenty minutes, five minutes for each technique, and eight to ten repetitions of each exercise (calf wall stretch, back knee straight, bilateral calf stretches, knees straight, ankle plantarflexion/dorsiflexion)

Locations

Country Name City State
Pakistan Faqraj Sharif Hospital (Trust) Physiotherapy and Orthopedic Department and Ramay Clinic (Physiotherapy and Orthopedic Department) Lahore Punjab

Sponsors (1)

Lead Sponsor Collaborator
Superior University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analog Scale subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between 0 for "no pain" and 10 for "worst pain". 12 Months
Primary Functional Disability Scale for Ankle (FADI) The FADI has 26 items. Each item is scored from 0 (unable to do) to 4 (no difficulty at all). The 4 pain items of the FADI are scored 0 (unbearable) to 4 (none). The FADI has a total point value of 104 points, whereas the FADI Sport has a total point value of 32 points. 12 months
Primary Range of motion (ROM) This tool measures the angle of dorsiflexion before and after the intervention, offering insights into the functional improvements resulting from the use of the portable wedge device. Additionally, participant satisfaction and compliance will be assessed through a structured questionnaire. 12 months
See also
  Status Clinical Trial Phase
Completed NCT02814565 - Cyclobenzaprine HCl Extended Release 15 mg Versus Placebo in Treatment of Cervical and/or Lower Back Pain Due to Muscle Spasms of Local Origin Phase 3
Recruiting NCT03570671 - Noninvasive Cardiac Imaging in Vasospastic Angina Korean Registry (NAVIGATOR) N/A
Completed NCT01155167 - Topical Radial Artery Vasodilation Phase 2/Phase 3
Completed NCT00001784 - Mexiletine for the Treatment of Focal Dystonia Phase 2
Completed NCT00001550 - Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS) Phase 1
Completed NCT00246389 - An Effectiveness and Safety Study of Cyclobenzaprine HCl Alone or in Combination With Ibuprofen for Acute Back or Neck Muscle Pain With Muscle Spasm Phase 4